Related Experiment Video
Updated: Jul 24, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
Vaginal Dose Reduction by Changing the Ovoid Loading Pattern in Image Guided Intracavitary Brachytherapy of Cervix
1Department of Radiation Oncology, Government Royapettah Hospital, 1, westcott road Royapettah, Chennai, 600014 India.
Journal of Obstetrics and Gynaecology of India
|December 25, 2023
Summary
Reducing ovoid loading in brachytherapy for cervical cancer significantly lowers rectal and vaginal doses. This approach minimizes vaginal morbidity without compromising the clinical target volume dose, offering a safer treatment option.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Locally advanced cervical cancer treatment often involves radiotherapy (external beam and brachytherapy).
- Radiotherapy can cause significant vaginal morbidity, a major clinical concern.
- Optimizing brachytherapy dosimetry is crucial for balancing treatment efficacy and side effects.
Purpose of the Study:
- To investigate the dosimetric impact of reducing ovoid loading in intracavitary brachytherapy for cervical cancer.
- To evaluate if decreased ovoid loading affects the dose delivered to the clinical target volume (CTV).
- To assess the potential for reducing radiation dose to organs at risk, specifically the rectum and vagina.
Main Methods:
- Analysis of 45 CT-based intracavitary brachytherapy plans from 15 patients.
- Comparison of three loading strategies: standard ovoid loading (A), reduced ovoid loading (B), and tandem-only loading (C).
- Generation of Dose-Volume Histograms and recording of dose-volume parameters for CTV, bladder, sigmoid, and rectum.
Main Results:
- No significant difference in D90 for the Clinical Target Volume (CTV) across all plan types (p=0.20).
- Statistically significant reductions in D2cc for the rectum (p<0.001) and vaginal dose points (p<0.001) with reduced ovoid loading (Plan B) and tandem-only (Plan C).
- No significant differences observed for D2cc bladder (p=0.09) or D2cc sigmoid (p=0.43).
Conclusions:
- Reducing ovoid loading in brachytherapy effectively lowers rectal and vaginal doses.
- This modification does not compromise the prescribed dose to the CTV, maintaining treatment efficacy.
- Tandem-only or reduced ovoid loading may be considered in select cervical cancer cases to mitigate vaginal morbidity.
Related Concept Videos
Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

